Search this site
Skip to main content
Skip to navigation
Haqq Laboratory
Home
Research
Team
Collaborators
Facilities
Publications
News
Contact
Haqq Laboratory
Home
Research
Team
Collaborators
Facilities
Publications
News
Contact
More
Home
Research
Team
Collaborators
Facilities
Publications
News
Contact
News
Rhythm Pharmaceuticals Announces Publication of Bardet-Biedl Syndrome Patient and Caregiver Perspectives of Hunger and Quality of Life with Setmelanotide | BioSpace
Rhythm Pharmaceuticals Announces Publication of Bardet-Biedl Syndrome Patient and Caregiver Perspectives of Hunger and Quality of Life with Setmelanotide - read this article along with other careers information, tips and advice on BioSpace
Combination of drugs for obesity and Type 2 diabetes may be more effective than a single therapy
Canadian and German researchers are working together to identify combinations of drugs that are more effective than single treatments, including surgery, to combat diabetes and obesity.
Rhythm Pharmaceuticals Presents New Data from Phase 3 Trial Evaluating Setmelanotide in Patients with Bardet-Biedl Syndrome (BBS) at the Pediatric Endocrine Society (PES) 2022 Virtual Annual Meeting
-- New data show setmelanotide treatment led to clinically meaningful improvements in lipid parameters, without affecting blood pressure or heart rate in...
Pediatricians can be hurtful when talking about kids' weight. Here's how to handle it
This is what parents can do when a doctor says something that sounds shaming.
The End of Insulin: Research Is Bringing Us Closer to a Cure Than Ever Before
Clinical trial for new anti-obesity drug ready to launch at U of A
Andrea Haqq is leading a new anti-obesity drug trial and genetic study at the Alberta Diabetes Institute
Rhythm’s Setmelanotide Trial, Testing Potential Anti-Obesity...
The University of Alberta, in Canada, is recruiting people with Bardet-Biedl syndrome and Alström syndrome for a pivotal Phase 3 trial testing the investigational anti-obesity therapy setmelanotide. The study, run by Rhythm Pharmaceuticals, which is developing the treatment, is expected to begin...
New mindset needed to better address the growing prevalence of childhood obesity and the weight stigma that comes with it
Shaping a Future Without Diabetes
A paediatrician with international training and experience is making a world of difference with practice and research In Edmonton.
HEROES – Summer 2013
The Summer issue of HEROES Magazine, the quarterly publication of the Stollery Children's Hospital Foundation.
Professor hopes new research could lead to breakthrough in disorder that affects young Canadians
A University of Alberta professor is hoping her research could lead to a breakthrough in treatment for a difficult condition that affects thousands of young Canadians.
Report abuse
Page details
Page updated
Report abuse